SCHEMBL4876389

SCHEMBL4876389

CC(CN1CCCCCCCCCCCCC1)N1CCCCCCCCCCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 2/20 0.39
ATM Q13315 2/20 0.39
ANPEP P15144 1/20 0.38
ERAP2 Q6P179 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
HRH3 Q9Y5N1 3/20 0.37
CHRM2 P08172 2/20 0.37
ADRA2B P18089 2/20 0.37
DRD3 P35462 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
MITF O75030 1/20 0.37
RAB9A P51151 1/20 0.37
PAX8 Q06710 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTGS1 P23219 2/20 0.36
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12022414 1.00 MEN1 (0.48) MEN1KMT2AMAPTATMANPEP
SCHEMBL2550467 0.97 MEN1 (0.44) MEN1KMT2AMAPTATMANPEP
SCHEMBL11066505 0.85 MEN1 (0.40) MEN1KMT2AMAPTATMANPEP
SCHEMBL9695349 0.81
SCHEMBL27565285 0.78 CYP3A4 (0.39) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL22663439 0.78 KDM4E (0.34) MEN1KMT2AALDH1A1ADRA2C
SCHEMBL20368812 0.76 HRH3 (0.40) MEN1KMT2AMAPTHRH3SIGMAR1
SCHEMBL23869469 0.76 CYP3A4 (0.38) MEN1KMT2AMAPTALDH1A1SMN1; SMN2
SCHEMBL425336 0.76 MEN1 (0.55) MEN1KMT2AMAPTATMANPEP
SCHEMBL426509 0.76 MEN1 (0.55) MEN1KMT2AMAPTATMANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005002522-A2 COMPOSITIONS AND METHODS FOR TREATING TISSUE ISCHEMIA CARITAS ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC. (US) 2005-01-13 WO claimed
EP-1991221-A2 METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION Genzyme Corporation (US) 2008-11-19 EP disclosed
WO-2007106063-A2 METHODS FOR INCREASING BLOOD FLOW AND/OR PROMOTING TISSUE REGENERATION GENZYME CORPORATION (US) 2007-09-20 WO disclosed